Evofem Biosciences Inc expected to post a loss of 37 cents a share - Earnings Preview

Evofem Biosciences

10/08/2021 24:54

* Evofem Biosciences Inc  EVFM.OQ   EVFM.O  is expected to show
a rise in quarterly revenue when it reports results on August
11. 
* The San Diego, California-based company is expected to report
revenue of $2.684 million, according to the mean estimate from 3
analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Evofem Biosciences Inc
is for a loss of 37 cents per share. For the same quarter last
year, the company reported a loss of 91 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Evofem
Biosciences Inc is $4.5​, about 81.1% above​ its last closing
price of $0.85. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.49       -0.49      -0.56     Missed  -14.9
 Dec. 31 2020  -0.40       -0.36      -0.50     Missed  -37.9
 Sep. 30 2020  -0.44       -0.44      -0.37     Beat    15.9​
 Jun. 30 2020  -0.37       -0.37      -0.91     Missed  -143.8
 Mar.          -0.33​      -0.32      -0.40     Missed  -25​
 31​ 2020​                                              
 Dec. 31 2019  -0.28       -0.29      -0.27     Beat    6.3​
 Sep. 30 2019  -0.31       -0.31      -0.30     Beat    3.8
 Jun. 30 2019  -0.37       -0.37      -0.41     Missed  -10.2
 This summary was machine generated August 9 at 23:54 GMT.  All
figures in US dollars unless otherwise stated